| [1] Armelin H A. Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proceedings of the National Academy of Science of the United States of America, 1973, 70(9): 2702-2706.
[2] Ornitz D M, Itoh N. The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol, 2015, 4(3): 215-266.
[3] Hoshikawa M, Ohbayashi N, Yonamine A, et al. Structure and expression of a novel fibroblast growth factor, FGF-17, preferentially expressed in the embryonic brain. Biochemical and Biophysical Research Communications, 1998, 244(1): 187-191.
[4] Ford-Perriss M, Abud H, Murphy M. Fibroblast growth factors in the developing central nervous system. Clinical and Experimental Pharmacology and Physiology, 2001, 28(7): 493-503.
[5] Xu J, Lawshe A, MacArthur C A, et al. Genomic structure, mapping, activity and expression of fibroblast growth factor 17. Mechanisms of Development, 1999, 83(1): 165-178.
[6] Zanni G, Barresi S, Travaglini L, et al. FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy-Walker malformation carrying a de novo 8p deletion. Neurogenetics, 2011, 12(3): 241-245.
[7] Katoh M, Katoh M. Comparative genomics on FGF8, FGF17, and FGF18 orthologs. International Journal Of Molecular Medicine, 2005, 16(3): 493-496.
[8] Itoh N, Ornitz D M. Functional evolutionary history of the mouse Fgf gene family. Developmental Dynamics, 2008, 237(1): 18-27.
[9] 时小燕,郭靓.成纤维细胞生长因子家族:生物学特性,病理生理学作用及相关治疗方法.国际药学研究杂志,2009,36(5):376-379. Shi X Y, Guo L. Fibroblast growth factor family: biological characteristics, pathophysiological role and related treatment methods. Journal of International Pharmaceutical Research, 2009, 36 (5): 376-379.
[10] Zhang X, Ibrahimi O A, Olsen S K, et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. Journal of Biological Chemistry, 2006, 281(23): 15694-15700.
[11] Ornitz D M, Xu J, Colvin J S, et al. Receptor specificity of the fibroblast growth factor family. Journal of Biological Chemistry, 1996, 271(25): 15292-15297.
[12] Spivak-Kroizman T, Lemmon M A, Dikic I, et al. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell, 1994, 79(6): 1015-1024.
[13] Yayon A, Klagsbrun M, Esko J D, et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 1991, 64(4): 841-848.
[14] Mohammadi M, Olsen S K, Ibrahimi O A. Structural basis for fibroblast growth factor receptor activation. Cytokine and Growth Factor Reviews, 2005, 16(2): 107-137.
[15] Ornitz D M. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays, 2000, 22(2): 108-112.
[16] Ornitz D M, Yayon A, Flanagan J G, et al. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Molecular and Cellular Biology, 1992, 12(1): 240-247.
[17] Maruoka Y,Ohbayashi N,Hoshikawa M,et al. Comparison of the expression of three highly related genes,Fgf8,Fgf17 and Fgf18,in the mouse embryo.Mechanisms of Development, 1998, 74(1-2): 175-177.
[18] Cholfin J A, Rubenstein J L. Patterning of frontal cortex subdivisions by Fgf17. Proceedings of the National Academy of Sciences, 2007, 104(18): 7652-7657.
[19] Xu J, Liu Z, Ornitz D M. Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures. Development, 2000, 127(9): 1833-1843.
[20] Yu X, Nieman B J, Sudarov A, et al. Morphological and functional midbrain phenotypes in fibroblast growth factor 17 mutant mice detected by Mn-enhanced MRI. Neuroimage, 2011, 56(3): 1251-1258.
[21] Scearce-Levie K, Roberson E D, Gerstein H, et al. Abnormal social behaviors in mice lacking Fgf17. Genes, Brain and Behavior, 2008, 7(3): 344-354.
[22] Bachler M, Neubüser A. Expression of members of the Fgf family and their receptors during midfacial development. Mechanisms of Development, 2001, 100(2): 313-316.
[23] Polnaszek N, Kwabi-Addo B, Wang J, et al. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. The Prostate, 2004, 60(1): 18-24.
[24] Heer R, Douglas D, Mathers M E, et al. Fibroblast growth factor 17 is over-expressed in human prostate cancer. The Journal of Pathology, 2004, 204(5): 578-586.
[25] Gauglhofer C, Sagmeister S, Schrottmaier W, et al. Up-Regulation of the Fibroblast Growth Factor 8 Subfamily in Human Hepatocellular Carcinoma for Cell Survival and Neoangiogenesis. Hepatology, 2011, 53(3): 854-864.
[26] Meijer D, Sieuwerts A M, Look M P, et al.. Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer. Endocrine-Related Cancer, 2008, 15(1): 101-111.
[27] Nezu M, Tomonaga T, Sakai C, et al. Expression of the fetal-oncogenic fibroblast growth factor-8/17/18 subfamily in human hematopoietic tumors. Biochemical and Biophysical Research Communications, 2005, 335(3): 843-849.
[28] Krejci P, Krakow D, Mekikian P B, et al. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage. Pediatric Research, 2007, 61(3): 267-272.
[29] Kettunen P, Furmanek T, Chaulagain R, et al. Developmentally regulated expression of intracellular Fgf11-13, hormone-like Fgf15 and canonical Fgf16, -17 and -20 mRNAs in the developing mouse molar tooth. Acta Odontologica Scandinavica, 2011, 69(6): 360-366.
[30] Machado M F, Portela V M, Price C A, et al. Regulation and action of fibroblast growth factor 17 in bovine follicles. Journal of Endocrinology, 2009, 202(3): 347-353.
[31] Miraoui H,Dwyer A A,Sykiotis G P,et al. Mutations in FGF17,IL17RD,DUSP6,SPRY4,and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet,2013,92(5):725-743. |
